Welcome to Francis Academic Press

Academic Journal of Business & Management, 2021, 3(4); doi: 10.25236/AJBM.2021.030404.

Analysis of Pfizer Inc. under COVID-19


Zhang, Aaron Zhexuan

Corresponding Author:
Zhang, Aaron Zhexuan

Basis International School Park Lane Harbor, Huizhou, 516000, China


Pfizer, a global pharmaceutical company, and the spearhead for a COVID-19 vaccine, is situated to grow in the future, through short-term vaccine rollout  and long-term development of oth-er pharmaceutical products and markets with its leading position in the pharmaceutical market. Pfiz-er stock has ample opportunity to grow in the future, both in the short and long term.


Pfizer; COVID-19, Vaccine, Pharmaceuticals, mRNA Vaccine, Company analysis

Cite This Paper

Zhang, Aaron Zhexuan. Analysis of Pfizer Inc. under COVID-19. Academic Journal of Business & Management (2021) Vol. 3, Issue 4: 15-17. https://doi.org/10.25236/AJBM.2021.030404.


[1]Macrotrends. Pfizer Revenue 2006-2020 | PFE. https://www.macrotrends.net/stocks/charts/PFE/pfizer/revenue

[2] Pfizer. Product Pipeline for New Pharmaceutical Drugs. Updated 10.27.2020. https://www.pfizer.com/science/drug-product-pipeline

[3] Mikulic, Matej. Pfizer's revenues in global submarkets from 2010 to 2019. Published 03.09.2020. https://www.statista.com/statistics/267877/revenues-of-pfizer-in-submarkets-worldwide/

[4] FDA. Pfizer-BioNTech COVID-19 Vaccine. Updated 12.29.2020. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine

[5] Guzman, Joseph. UN warns of rise in zoonotic diseases due to human activity. Published 07.07.2020 https://thehill.com/changing-america/sustainability/environment/506176-un-warns-of-rise-in-zoonotic-diseases-due-to

[6] Mikulic, Matej. Distribution of the total global pharmaceutical market sales from 2014 to 2019, by submarket. Published 04.09.2020. https://www.statista.com/statistics/266547/total-value-of-world-pharmaceutical-market-by-submarket-since-2006/

[7] Garde, Damian. The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race. Published 10.10.2020. https://www.statnews.com/2020/11/10/the-story-of-mrna-how-a-once-dismissed-idea-became-a-leading-technology-in-the-covid-vaccine-race/

[8] Cohen, Elizabeth. Pfizer's ultra-cold vaccine, a 'very complex' distribution plan and an exploding head emoji. Updated 11.11.2020. https://www.cnn.com/2020/11/10/health/pfizer-vaccine-distribution-cold-chain/index.html

[9] Roberts, Joanna. Five things you need to know about: mRNA vaccines. Published 04.01.2020. https://horizon-magazine.eu/article/five-things-you-need-know-about-mrna-vaccines.html

[10] Wind Financial. Pfizer. 

[11]Macrotrends. Pfizer ROE 2006-2020 | PFE. https://www.macrotrends.net/stocks/charts/PFE/pfizer/roe

[12]Macrotrends. Pfizer ROA 2006-2020 | PFE. https://www.macrotrends.net/stocks/charts/PFE/pfizer/roa

[13]Macrotrends. Pfizer Quick Ratio 2006-2020 | PFE. https://www.macrotrends.net/stocks/charts/PFE/pfizer/quick-ratio

[14]Macrotrends. AstraZeneca Quick Ratio 2006-2020 | AZN. https://www.macrotrends.net/stocks/charts/AZN/astrazeneca/quick-ratio

[15]Macrotrends. Johnson & Johnson Quick Ratio 2006-2020 | JNJ. https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/quick-ratio

[16]Macrotrends. GlaxoSmithKline Quick Ratio 2006-2020 | GSK. https://www.macrotrends.net/stocks/charts/GSK/glaxosmithkline/quick-ratio

[17] Llamas, Michelle. Pfizer. Updated 12.14.2020. https://www.drugwatch.com/manufacturers/pfizer/

[18] BMJ. Covid-19: Pfizer vaccine efficacy was 52% after first dose and 95% after second dose, pa-per shows. 2020;371:m4826. Published 12.11.2020. https://www.bmj.com/content/371/bmj.m4826

[19] Bajpai, Prableen. Top 5 Spenders in R&D in Biotech. Published 08.12.2020. https://www.nasdaq.com/articles/top-5-spenders-in-rd-in-biotech-2020-08-12